Research and Development

Showing 15 posts of 9599 posts found.

Catalent continues investment in Global Clinical Supply services with German warehousing & controlled substance expansion

March 13, 2012 Research and Development

Somerset, NJ – March 7, 2012 — Catalent Pharma Solutions announced the completion of extended warehousing facilities in Schorndorf, Germany …

Catalent Expert Presents on Protein Expression in CHO Cells: Comparison of GPEx® Technology to Traditional Cell Line Engineering at Cell Culture World Congress 2012

March 13, 2012 Research and Development

Somerset, NJ February 21, 2012 — Michael Jenkins, Ph.D., General Manager of Catalent Pharma Solutions’ Middleton, WI facility, will present …
john_brown

Dr John Brown joins BioCity Nottingham’s board

March 13, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BioCity Nottingham, BioCity Scotland, John Brown

Dr John Brown has been appointed as a non-executive director to the board of BioCity Nottingham Ltd, which runs one …

GSK expands apprenticeship programme

March 13, 2012 Manufacturing and Production, Research and Development GSK, Hayes, R&D, manufacturing

GlaxoSmithKline has expanded its apprenticeship programme with the creation of positions spanning manufacturing, IT, and R&D.  The multi-disciplinary scheme is …
Zytiga image

Strong Zytiga study results could increase uptake

March 12, 2012 Research and Development, Sales and Marketing IDMC, Janssen, Provenge, Zytiga, prostate

Janssen’s prostate cancer pill Zytiga could be on course to target a larger number of patients following a positive late-stage …
roch_d_ucb

UCB chief executive to chair IMI

March 12, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing IMI, Roch, UCB

UCB has confirmed that its chief executive Roch Doliveux has been appointed chairman of the governing board of the Innovative …
caprelsa image

Major new drugs for 2012

March 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Caprelsa, Eylea, Manjor new drugs, Xalkori, Zelboraf, avastin, inlyta

 Renal cell carcinoma Pfizer’s Inlyta (axitinib) has been approved as second line treatment for renal cell carcinoma. The drug is …

Keep Alzheimer’s patients on Aricept for longer, study says

March 8, 2012 Research and Development, Sales and Marketing Aricept, Pfizer, Teva, donepezil

Patients with severe forms of Alzheimer’s disease should stay on Pfizer’s Aricept for longer, according to new research. A new …
mark_baker_photograph2

NICE appoints two new directors

March 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Baker, NICE

The National Institute for Health and Clinical Excellence (NICE) has appointed two new directors. Professor Mark Baker will be the …

Ranbaxy launches generic Lipitor in Europe

March 6, 2012 Research and Development, Sales and Marketing Lipitor, Pfizer, Ranbaxy, atorvastatin, generics

Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date.  The Indian …

Using the corporate brand in pharma

March 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Marks, MSI, brand, branding, brands

In many markets the corporate brand can add significant value and values to the portfolio of product brands and franchises. …
catherine_meaden

ABPI appoints Catherine Meaden as head of policy and public affairs

March 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS Direct, VBP

The ABPI has appointed Catherine Meaden as its new head of policy and public affairs. She will join the UK …
gsk_hq_logo

GSK collaborates with Dundee on neglected diseases

March 6, 2012 Research and Development, Sales and Marketing Africa, Dundee, GSK, Gates, Wellcome

GlaxoSmithKline has teamed up with Dundee University and the Wellcome Trust to develop new drugs for neglected diseases.  Healthcare charity …

Mundipharma appoints Paul Medeiros as head of corporate and business development

March 6, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, Medeiros, Mundipharma

Mundipharma International has appointed Paul Medeiros as its new head of corporate and business development at its Cambridge, UK site.  …

Contract research news in brief

March 5, 2012 Research and Development CPR, Celeron/Ricerca, Certara, PRA, Quintiles

CPR opens first bioanalytical lab in Singapore, PRA wins an MS vaccine trial contract, plus M&A and alliance news from …
The Gateway to Local Adoption Series

Latest content